Intrinsic Value of S&P & Nasdaq Contact Us

Enlivex Therapeutics Ltd. ENLV

NASDAQ Capital Marke

SharesGrow Score
68/100
3/6 Pass
SharesGrow Intrinsic Value
$470.92
+58691.5%
Analyst Price Target
$15.00
+1772.7%

Enlivex Therapeutics Ltd. (ENLV) current share price is $0.80. The gold spot price is $4,825.20 per troy ounce. Using the formula: ENLV in gold = $0.80 × 31.1035 ÷ $4,825.20 = 0.0052 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of ENLV when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding ENLV shares over the measured period.

ENLV in US Dollars
Gold in US Dollars
ENLV in Gold (grams per share)

Real Wealth Growth Rate

ENLV
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{ENLV}_{\text{gold}}(t) = \frac{P_{\text{ENLV}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{ENLV}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{ENLV}_{\text{gold}}^{(T)}}{\text{ENLV}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{ENLV}_\text{gold}^{(0)}$ = initial gold-price, $\text{ENLV}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

MRUS
MRUS
Merus N.V.
$90.00
+0.00%
VCEL
VCEL
Vericel Corporation
$35.14
+2.03%
CRVS
CRVS
Corvus Pharmaceuticals, Inc.
$15.25
+0.53%
KROS
KROS
Keros Therapeutics, Inc.
$11.55
+3.59%
CKPT
CKPT
Checkpoint Therapeutics, Inc.
$4.26
+0.00%
IPSC
IPSC
Century Therapeutics, Inc.
$2.37
+4.41%
PLX
PLX
Protalix BioTherapeutics, Inc.
$2.36
+3.06%
ALDX
ALDX
Aldeyra Therapeutics, Inc.
$1.79
-0.56%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message